Maitri Enterprises

Ahmedabad, India Founded: 1991 • Age: 35 yrs Listed
Pharmaceutical products and medical devices are distributed in India.

About Maitri Enterprises

Maitri Enterprises is a publicly listed company based in Ahmedabad (India) founded in 1991. Pharmaceutical products and medical devices are distributed in India. Its Indian entity Maitri Enterprises Limited reported revenue of β‚Ή33.72 Cr. Maitri Enterprises offers products and services including Corporate Services. Its focus areas include Medical Device Distributors, Pharmaceutical Distributors and Diversified. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.

Company details

Maitri Enterprises was established in 1991 and is headquartered in Ahmedabad, India. Operations focus on the distribution of pharmaceutical products and medical devices within the healthcare sector. The company is managed by Jaikishan R Ambwani as Managing Director. Activities encompass supply chain logistics and product sourcing for regional markets, supporting medical and pharmaceutical needs across the country.

  • Headquarters Ahmedabad, India
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website maitrienterprises.com
  • Legal Name Maitri Enterprises Ltd.
Key Metrics
  • Market Cap
    ₹14.34 Cr

    MAITRI · BSE

  • Share Price
    ₹32.59

    0.00% today

  • Revenue
    ₹33.30 Cr

    FY 2025-26 · +16.0% YoY

  • EBITDA
    ₹1.29 Cr

    Margin 3.9%

  • Net Profit
    ₹0.60 Cr

    FY 2025-26 · -37.5% YoY

  • P/E (TTM)
    18.0x

    P/B 2.9x

Products & Services of Maitri Enterprises

Maitri Enterprises offers a comprehensive portfolio of products and services, including Corporate Services.

Corporate Services
Financial Services

Manages company governance and compliance information

Board of directors of Maitri Enterprises Limited (Maitri Enterprises)

Maitri Enterprises Limited is the primary company behind Maitri Enterprises. The boards of the 2 registered companies of Maitri Enterprises currently have 8 directors; the longest-serving is Rameshlal Ambwani Bullchand, appointed in 2011. 20 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rameshlal Ambwani Bullchand
DIN 02427779
Director14 Jul 201115 yrs 3 moMaitri Enterprises Limited
Nilesh Carpenter
DIN 08704659
Designated Partner19 Feb 20206 yrs 8 moDr Zag Ambwani (India) Llp
Sarla Jaikishan Ambwani
DIN 06712878
Designated Partner19 Feb 20206 yrs 8 moDr Zag Ambwani (India) Llp, Maitri Enterprises Limited
Chanderlal Ambwani Bulchand
DIN 01390563
Designated Partner19 Feb 20206 yrs 8 moDr Zag Ambwani (India) Llp
Jaikishan Rameshlal Ambwani
DIN 03592680
Designated Partner25 Jun 20206 yrs 4 moDr Zag Ambwani (India) Llp, Maitri Enterprises Limited
Deepak Ambwani
DIN 03054773
Director10 Nov 20205 yrs 11 moMaitri Enterprises Limited
Rakesh S Lakhani
DIN 09239137
Director14 Jul 20215 yrs 3 moMaitri Enterprises Limited
Bharat Ramjibhai Sisodia
DIN 11327540
Additional Director14 Nov 202511 moMaitri Enterprises Limited

People of Maitri Enterprises

1 people are tracked at Maitri Enterprises (1 in leadership).

NameRoleGroup
Managing DirectorLeadership
Premium access

Complete people profiles for Maitri Enterprises

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Maitri Enterprises

Maitri Enterprises is a publicly listed company on the BSE with ticker symbol MAITRI in India, operating in the Non-energy minerals sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date25 Nov 2011
  • Listed onBSE: 513430
  • Listed entityMaitri Enterprises Ltd.
  • Exchange sectorNon-energy minerals
  • ISININE501L01024
  • Share price₹41.00 · 2026-10-13
  • Volume (last session)1

Financials of Maitri Enterprises

Exchange-reported figures of Maitri Enterprises Limited, the listed company behind Maitri Enterprises (BSE: MAITRI).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹33.30 Cr
+16.0% YoY
EBITDA
₹1.29 Cr
+14.2% YoY
Profit After Tax
₹0.60 Cr
-37.5% YoY
Net Worth
₹5.26 Cr
+11.9% YoY
Total Assets
₹10.18 Cr
-12.3% YoY
Total Debt
₹4.83 Cr
-29.9% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Income statement
Revenue33.3028.7019.0113.3320.09
Revenue growth+16.0%+51.0%+42.6%-33.7%-
EBITDA1.291.130.240.510.69
EBITDA margin+3.9%+3.9%+1.3%+3.8%+3.4%
Profit before tax0.920.33(0.42)0.180.34
Net profit0.600.96(0.46)0.020.23
Net profit margin+1.8%+3.3%-2.4%+0.2%+1.1%
EPS (β‚Ή)1.370.38(1.02)0.000.51
Balance sheet
Total assets10.1811.6115.0911.3110.69
Net worth5.264.704.524.974.97
Total debt4.836.8910.546.345.72
Cash & bank0.510.430.550.450.42
Net working capital5.847.439.739.489.03
Cash flow
Cash from operations3.093.040.060.02(0.39)
Cash from investing(0.24)1.23(3.45)(0.24)(3.27)
Cash from financing(2.76)(4.40)3.490.243.69
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue5.2013.914.667.766.975.887.717.34
Revenue growth (YoY)-25.4%+136.6%-39.6%+5.7%-9.7%---
Other income0.000.040.010.300.07(0.06)0.020.08
EBITDA(0.28)0.790.900.31(0.70)(0.31)0.220.94
EBITDA margin-5.4%+5.7%+19.3%+4.0%-10.0%-5.3%+2.9%+12.8%
Depreciation0.030.010.030.020.020.020.020.02
Interest0.080.150.190.200.180.130.190.42
Profit before tax(0.39)0.670.690.39(0.83)(0.52)0.030.58
Tax0.080.210.27(0.02)(0.14)(0.49)0.430.16
Net profit(0.47)0.460.420.41(0.69)(0.03)(0.40)0.42
EPS (β‚Ή)(1.05)1.070.950.93(1.58)(0.04)(0.89)0.99
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue32.1928.6618.359.9012.584.556.66
Revenue growth+12.3%+56.2%+85.4%-21.3%+176.5%-31.7%-
EBITDA1.361.210.460.580.410.09(0.01)
EBITDA margin+4.2%+4.2%+2.5%+5.9%+3.3%+2.0%-0.2%
Profit before tax1.140.450.120.460.300.100.21
Net profit0.821.140.080.320.220.060.16
Net profit margin+2.6%+4.0%+0.4%+3.2%+1.8%+1.3%+2.4%
EPS (β‚Ή)1.850.680.180.770.500.380.86
Balance sheet
Total assets10.8612.0115.407.716.732.452.08
Net worth6.475.695.385.304.962.041.97
Total debt4.306.309.992.411.770.400.11
Cash & bank0.300.330.340.260.160.180.14
Net working capital2.943.485.152.892.101.170.96
Cash flow
Cash from operations1.562.60(1.70)(0.20)(0.62)(0.17)0.64
Cash from investing1.071.78(5.24)(0.26)(3.39)(0.06)(0.62)
Cash from financing(2.65)(4.39)7.030.553.990.27(0.01)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue5.2013.614.667.766.175.887.717.33
Revenue growth (YoY)-15.7%+131.5%-39.6%+5.9%-19.8%---
Other income0.020.240.040.110.11(0.06)0.020.08
Total expenses4.8612.783.767.386.916.177.486.34
EBITDA0.340.830.900.38(0.74)(0.29)0.230.99
EBITDA margin+6.5%+6.1%+19.3%+4.9%-12.0%-4.9%+3.0%+13.5%
Depreciation0.020.010.030.020.020.020.020.02
Interest0.070.140.170.190.160.120.170.41
Profit before tax0.270.920.740.28(0.81)(0.49)0.060.64
Tax0.080.21(0.18)(0.02)(0.14)(0.49)0.430.16

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 27 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue5.2013.914.667.766.975.887.717.34
Revenue growth (YoY)-25.4%+136.6%-39.6%+5.7%-9.7%---
Other income0.000.040.010.300.07(0.06)0.020.08
EBITDA(0.28)0.790.900.31(0.70)(0.31)0.220.94
EBITDA margin-5.4%+5.7%+19.3%+4.0%-10.0%-5.3%+2.9%+12.8%
Depreciation0.030.010.030.020.020.020.020.02
Interest0.080.150.190.200.180.130.190.42
Profit before tax(0.39)0.670.690.39(0.83)(0.52)0.030.58
Tax0.080.210.27(0.02)(0.14)(0.49)0.430.16
Net profit(0.47)0.460.420.41(0.69)(0.03)(0.40)0.42
EPS (β‚Ή)(1.05)1.070.950.93(1.58)(0.04)(0.89)0.99
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Revenue33.3028.7019.0113.3320.09
Revenue growth+16.0%+51.0%+42.6%-33.7%-
Other income0.420.040.130.110.06
Total expenses32.0127.5718.7712.8219.40
Employee cost0.000.720.950.750.80
EBITDA1.291.130.240.510.69
EBITDA margin+3.9%+3.9%+1.3%+3.8%+3.4%
Depreciation0.080.070.060.070.09
Interest0.710.770.730.370.32
Profit before tax0.920.33(0.42)0.180.34
Tax0.320.160.040.160.11
Net profit0.600.96(0.46)0.020.23
Net profit margin+1.8%+3.3%-2.4%+0.2%+1.1%
EPS (β‚Ή)1.370.38(1.02)0.000.51
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Equity & liabilities
Share capital4.404.404.404.404.40
Reserves & surplus0.860.300.120.570.57
Shareholders' funds (net worth)5.264.704.524.974.97
Minority interest0.000.000.000.000.00
Secured loans2.222.950.031.740.05
Unsecured loans2.613.9410.514.605.67
Total debt4.836.8910.546.345.72
Total liabilities10.1811.6115.0911.3110.69
Assets
Gross block1.130.900.820.760.73
Net block0.390.240.230.230.28
Capital work in progress0.000.000.000.000.00
Investments3.743.743.920.270.27
Inventories4.145.736.507.926.13
Sundry debtors5.195.418.757.478.94
Cash & bank balances0.510.430.550.450.42
Loans & advances0.450.610.520.730.39
Total current assets10.2912.1816.3216.5715.88
Total current liabilities4.454.756.597.096.85
Net working capital5.847.439.739.489.03
Total assets10.1811.6115.0911.3110.69
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Opening cash0.430.550.450.420.39
Net cash from operating activities3.093.040.060.02(0.39)
Net cash from investing activities(0.24)1.23(3.45)(0.24)(3.27)
Net cash from financing activities(2.76)(4.40)3.490.243.69
Net change in cash0.09(0.12)0.100.020.03
Closing cash0.510.430.550.450.42
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Growth
Sales growth+16.0%+51.0%+42.6%-33.7%-
EBITDA growth+14.2%+370.8%-52.9%-26.1%-
PBT growth+178.8%+9998.0%--47.1%+9997.0%
Net income growth-37.5%+308.7%-2400.0%-91.3%-
Revenue CAGR (3Y)+35.7%+12.6%---
EBITDA CAGR (3Y)+36.3%+17.9%---
Profitability & leverage
Net income margin+1.8%+0.6%-2.4%+0.2%+1.1%
Return on capital employed-+15.8%0.0%+4.9%+6.2%
Return on net worth-+20.8%0.0%0.0%+4.6%
Debt / equity-1.891.781.211.15
Long-term debt / equity-1.491.140.420.64
Interest cover58.6872.64405.5684.0953.33
Efficiency & per share
Fixed asset turnover-33.3724.0617.8927.52
Inventory turnover-4.692.641.903.28
Debtors turnover-4.052.341.622.25
EPS (β‚Ή)1.370.38(1.02)0.000.51
Dividend per share (β‚Ή)0.000.000.000.000.00
Book value per share (β‚Ή)0.0010.6710.2711.2911.29
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue5.2013.614.667.766.175.887.717.33
Revenue growth (YoY)-15.7%+131.5%-39.6%+5.9%-19.8%---
Other income0.020.240.040.110.11(0.06)0.020.08
Total expenses4.8612.783.767.386.916.177.486.34
EBITDA0.340.830.900.38(0.74)(0.29)0.230.99
EBITDA margin+6.5%+6.1%+19.3%+4.9%-12.0%-4.9%+3.0%+13.5%
Depreciation0.020.010.030.020.020.020.020.02
Interest0.070.140.170.190.160.120.170.41
Profit before tax0.270.920.740.28(0.81)(0.49)0.060.64
Tax0.080.21(0.18)(0.02)(0.14)(0.49)0.430.16
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue32.1928.6618.359.9012.584.556.66
Revenue growth+12.3%+56.2%+85.4%-21.3%+176.5%-31.7%-
Other income0.510.040.260.030.030.080.27
Total expenses30.8327.4517.899.3212.174.466.67
Employee cost0.000.720.930.570.580.360.27
EBITDA1.361.210.460.580.410.09(0.01)
EBITDA margin+4.2%+4.2%+2.5%+5.9%+3.3%+2.0%-0.2%
Depreciation0.070.070.050.060.070.050.04
Interest0.660.730.550.090.070.020.01
Profit before tax1.140.450.120.460.300.100.21
Tax0.320.160.040.140.080.040.05
Net profit0.821.140.080.320.220.060.16
Net profit margin+2.6%+4.0%+0.4%+3.2%+1.8%+1.3%+2.4%
EPS (β‚Ή)1.850.680.180.770.500.380.86
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital4.404.404.404.404.401.901.90
Reserves & surplus2.071.290.980.900.560.140.07
Shareholders' funds (net worth)6.475.695.385.304.962.041.97
Secured loans2.222.950.030.030.050.080.00
Unsecured loans2.083.359.962.381.720.320.11
Total debt4.306.309.992.411.770.400.11
Total liabilities10.8612.0115.407.716.732.452.08
Assets
Gross block0.860.630.550.490.460.430.27
Net block0.330.170.160.150.180.220.10
Capital work in progress0.000.000.000.000.000.000.00
Investments6.836.837.023.373.370.000.00
Inventories4.144.675.365.934.163.142.23
Sundry debtors2.492.305.261.862.331.571.10
Cash & bank balances0.300.330.340.260.160.180.14
Loans & advances0.410.620.450.600.360.230.07
Total current assets7.347.9211.418.657.015.123.54
Total current liabilities4.404.446.265.764.913.952.58
Net working capital2.943.485.152.892.101.170.96
Total assets10.8612.0115.407.716.732.452.08
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.330.340.260.160.180.140.12
Net cash from operating activities1.562.60(1.70)(0.20)(0.62)(0.17)0.64
Net cash from investing activities1.071.78(5.24)(0.26)(3.39)(0.06)(0.62)
Net cash from financing activities(2.65)(4.39)7.030.553.990.27(0.01)
Net change in cash(0.03)(0.02)0.090.09(0.01)0.040.01
Closing cash0.300.330.340.260.160.180.14
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+12.3%+56.2%+85.4%-21.3%+176.5%-31.7%-
EBITDA growth+12.4%+163.0%-20.7%+41.5%+355.6%+1000.0%-
PBT growth+153.3%+275.0%-73.9%+53.3%+200.0%-52.4%+2000.0%
Net income growth-28.1%+1325.0%-75.0%+45.5%+266.7%-62.5%-
Revenue CAGR (3Y)+48.2%+31.6%+59.2%+14.1%+26.9%+87.5%+118.3%
EBITDA CAGR (3Y)+32.9%+43.4%+72.3%----41.5%
Profitability & leverage
Net income margin+2.6%+1.0%+0.4%+3.2%+1.8%+1.3%+2.4%
Return on capital employed-+16.1%+5.8%+7.8%+8.1%+5.8%+11.1%
Return on net worth-+20.8%+1.5%+6.6%+6.3%+3.5%+8.3%
Debt / equity-1.471.160.410.310.130.03
Long-term debt / equity-1.200.950.030.060.120.03
Interest cover51.1664.04134.1517.3120.5950.00-20.00
Efficiency & per share
Fixed asset turnover-48.5835.2920.8428.2713.0025.13
Inventory turnover-5.713.251.963.451.693.18
Debtors turnover-7.585.154.736.453.415.37
EPS (β‚Ή)1.850.680.180.770.500.380.86
Dividend per share (β‚Ή)0.000.000.000.000.000.000.00
Book value per share (β‚Ή)0.0012.9312.2312.0511.2810.7610.38

Similar companies to Maitri Enterprises

Maitri Enterprises has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$8.98M161
Provider of medical equipment, devices, and drugs distribution services
Premium access

Detailed similar companies of Maitri Enterprises

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Maitri Enterprises

Premium access

Complete news archive for Maitri Enterprises

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maitri Enterprises

Maitri Enterprises was founded in 1991.

Maitri Enterprises is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

The primary company behind Maitri Enterprises, Maitri Enterprises Limited, reported revenue of β‚Ή33.72 Cr for FY 2026, up 16% year on year.

Maitri Enterprises was established in 1991 and is headquartered in Ahmedabad, India. Operations focus on the distribution of pharmaceutical products and medical devices within the healthcare sector. The company is managed by Jaikishan R Ambwani as Managing Director. Activities encompass supply chain logistics and product sourcing for regional markets, supporting medical and pharmaceutical needs across the country.

Maitri Enterprises's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.

Maitri Enterprises offers Corporate Services.

Yes, Maitri Enterprises is publicly traded on BSE under the ticker symbol MAITRI.

Maitri Enterprises is associated with 2 legal entities: Maitri Enterprises Limited, Dr Zag Ambwani (India) Llp.

The legal entities of Maitri Enterprises currently have 9 directors, including Nilesh Carpenter, Sarla Jaikishan Ambwani, Jaikishan Rameshlal Ambwani and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available